Stay updated on Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ClinicalTrials.gov record for the FRESCO-2 fruquintinib trial is available, with detailed study information, results measures, participant criteria, and publications.SummaryDifference100%

- Check16 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces an NIH-wide transition notice about using “Super Intelligence” instead of “Artificial Intelligence.” The study record itself remains unavailable.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedAccess to the study record now shows a 403 Forbidden page, replacing the intended content with an error message and standard site chrome. This indicates the page is blocked rather than updated with study data.SummaryDifference18%

Stay in the know with updates to Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.